what percentage of stereotactic breast biopsies are cancer

Release time ：Dec-22,2024

Stereotactic breast biopsy is a crucial diagnostic procedure for evaluating the nature of suspicious lesions within the breast. Typically, between 20% and 30% of these biopsies reveal malignant tumors. When interpreting this figure, it's essential to grasp the context in which stereotactic breast biopsies are used. This technique is primarily employed for further assessment of breast microcalcifications or lesions with atypical radiographic features. Given the small size and diagnostic challenges these lesions present, stereotactic biopsy emerges as an indispensable diagnostic instrument. Physicians consider various factors, including clinical presentation and radiographic characteristics, to determine the necessity of a stereotactic biopsy. Patients recommended for this procedure should not be overly alarmed. While there is a chance of identifying malignant tumors, many of these lesions are benign. Moreover, even in cases where cancer is confirmed, early detection and adherence to standard treatment protocols generally result in favorable outcomes. Thus, maintaining composure and actively engaging with medical examinations and treatments is vital when dealing with breast disease screening and diagnosis.